Clinical Trials Insight: 700039895
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2010
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Pacira Pharmaceuticals
- 15 Dec 2010 According to a Pacira Pharmaceuticals Inc media release, the US FDA has accepted the NDA for Exparel [bupivacaine] for the treatment of postoperative pain.
- 18 Dec 2008 New trial record.